Joris Erdmann
Overview
Explore the profile of Joris Erdmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Augustinus S, Sijberden J, Bieze M, Agarwal V, Aldrighetti L, Alseidi A, et al.
BJS Open
. 2025 Mar;
9(1).
PMID: 40036750
Background: Patients undergoing hepato-pancreato-biliary surgery are typically preoperatively assessed using the American Society of Anesthesiologists (ASA) classification, which is also used for case-mix adjustment when comparing centre outcomes. Studies determining...
2.
Reese T, Gilg S, Erdmann J, Jonas E, Oldhafer K, Sparrelid E
HPB (Oxford)
. 2025 Mar;
PMID: 40023722
Background: Accurate assessment of the future liver remnant (FLR) is crucial for predicting the risk of post-hepatectomy liver failure (PHLF). This survey aims to evaluate the current practices of liver...
3.
Menso J, Francken M, de Graaf N, Bonomi A, Guastella R, Balaban D, et al.
Ann Surg
. 2025 Feb;
PMID: 39928538
Objective: To perform a cost-analysis during the implementation of robot-assisted pancreatoduodenectomy (RPD) in a high-volume center. Background: Many high-volume centers are implementing RPD as alternative to open pancreatoduodenectomy (OPD) but...
4.
Smits J, Chau S, James S, Korenblik R, Tschogl M, Arntz P, et al.
HPB (Oxford)
. 2024 Sep;
26(12):1458-1466.
PMID: 39277435
Background: Major hepatectomy in perihilar cholangiocarcinoma (pCCA) patients with a small future liver remnant (FLR) risks posthepatectomy liver failure (PHLF). This study examines combined portal and hepatic vein embolisation (PVE/HVE)...
5.
Nooijen L, van der Snee L, Ten Haaft B, Kazemier G, Klumpen H, Bridgewater J, et al.
HPB (Oxford)
. 2023 Oct;
26(2):179-187.
PMID: 37891150
Background: There is currently no evidence to support structured use of imaging or biomarkers during follow-up of patients after curative resection of biliary tract cancer (BTC). Besides, the influence of...
6.
Primavesi F, Maglione M, Cipriani F, Denecke T, Oberkofler C, Starlinger P, et al.
Br J Surg
. 2023 Aug;
110(10):1331-1347.
PMID: 37572099
Background: Posthepatectomy liver failure (PHLF) contributes significantly to morbidity and mortality after liver surgery. Standardized assessment of preoperative liver function is crucial to identify patients at risk. These European consensus...
7.
Arntz P, Deroose C, Marcus C, Sturesson C, Panaro F, Erdmann J, et al.
HPB (Oxford)
. 2023 Jul;
25(10):1131-1144.
PMID: 37394397
Purpose: The aim of this joint EANM/SNMMI/IHPBA procedure guideline is to provide general information and specific recommendations and considerations on the use of [Tc]Tc-mebrofenin hepatobiliary scintigraphy (HBS) in the quantitative...
8.
Gorgec B, Zonderhuis B, Besselink M, Erdmann J, Kazemier G, Swijnenburg R
J Vis Exp
. 2022 Jul;
(184).
PMID: 35815955
Biliary cysts (BC) are rare congenital dilatations of intra- and extrahepatic parts of the biliary tract and bear a significant risk of carcinogenesis. Surgery is the cornerstone treatment for patients...
9.
Heil J, Heid F, Bechstein W, Bjornsson B, Brismar T, Carling U, et al.
HPB (Oxford)
. 2021 Sep;
24(3):413-421.
PMID: 34526229
Background: After portal vein embolization (PVE) 30% fail to achieve liver resection. Malnutrition is a modifiable risk factor and can be assessed by radiological indices. This study investigates, if sarcopenia...
10.
Xu Y, Campos Carrascosa L, Yeung Y, Chu M, Yang W, Djuretic I, et al.
Cancer Immunol Res
. 2021 Aug;
9(10):1141-1157.
PMID: 34376502
The use of cytokines for immunotherapy shows clinical efficacy but is frequently accompanied by severe adverse events caused by excessive and systemic immune activation. Here, we set out to address...